Renal–hepatic–pancreatic dysplasia

Classification	OMIM: 208540;
External resources	Orphanet: 294415;

Renal–hepatic–pancreatic dysplasia
Renal–hepatic–pancreatic dysplasia
Other names: Ivemark II syndrome, Renohepaticopancreatic dysplasia
	Gross photo of liver and pancreas showing multiple cysts in the latter in a patient with renal–hepatic–pancreatic dysplasia

Renal–hepatic–pancreatic dysplasia is an autosomal recessive congenital disorder characterized by pancreatic fibrosis, renal dysplasia and hepatic dysgenesis. It is usually fatal soon after birth.^{[citation needed]}An association with NPHP3 has been described.^[1] It was characterized in 1959.^[2]^[3]

References

↑ Bergmann C, Fliegauf M, Brüchle NO, et al. (April 2008). "Loss of nephrocystin-3 function can cause embryonic lethality, Meckel-Gruber-like syndrome, situs inversus, and renal-hepatic-pancreatic dysplasia". Am. J. Hum. Genet. 82 (4): 959–970. doi:10.1016/j.ajhg.2008.02.017. PMC 2427297. PMID 18371931.
↑ Vankalakunti M, Gupta K, Kakkar N, Das A (2007). "Renal-hepatic-pancreatic dysplasia syndrome (Ivemark's syndrome)". Diagn Pathol. 2: 24. doi:10.1186/1746-1596-2-24. PMC 1919354. PMID 17605805.{{cite journal}}: CS1 maint: unflagged free DOI (link)
↑ IVEMARK BI, OLDFELT V, ZETTERSTROM R (January 1959). "Familial dysplasia of kidneys, liver and pancreas: a probably genetically determined syndrome". Acta Paediatr. 48 (1): 1–11. doi:10.1111/j.1651-2227.1959.tb16011.x. PMID 13626573. S2CID 196353197.

This genetic disorder article is a stub. You can help MDWiki by expanding it.

Renal–hepatic–pancreatic dysplasia
Other names: Ivemark II syndrome, Renohepaticopancreatic dysplasia

Gross photo of liver and pancreas showing multiple cysts in the latter in a patient with renal–hepatic–pancreatic dysplasia

Classification	OMIM: 208540
External resources	Orphanet: 294415